Human umbilical cord-derived Mesenchymal stem cells to improve ovarian production and increase fertility in women.

Some of the causes for infertility includes low AMH (Anti-Müllerian Hormone), diminished ovarian reserve or premature ovarian failure. In these cases, women undergo several in vitro fertilization (IVF) cycles, with little success, or with results of very few and low quality eggs retrieved each cycle.

For patients with low AMH or diminished ovarian reserve, mesenchymal stem cells in combination with certain peptides have shown to increase AMH, follicle count and help with egg quality.

Our unique approach includes Mesenchymal stem cells administered intravenously in combination with ovarian peptides, to be done prior to any IVF or egg retrieval cycle for better results.


Citations and Scientific References

Our medical unit is highly esteemed for partnering globally with fellow researchers on scientific studies and contributing to respected scientific journals.

View References